Bipartisan Bill Would Require Written Consent for VA Psychiatric Drug Prescriptions
A coalition of 35 national veterans organizations sent a letter last month pressing House and Senate Veterans’ Affairs Committee leaders to prioritize legislation requiring written informed consent before the Department of Veterans Affairs prescribes psychiatric medications.
abcnews.go.comApproximately 35 national veterans organizations sent a letter last month to leaders of the House and Senate Veterans’ Affairs Committees urging them to prioritize the Written Informed Consent Act. The American Legion, Disabled American Veterans, Veterans of Foreign Wars and Iraq and Afghanistan Veterans of America were among the signatories.
“The legislation will ensure veterans are fully informed about a drug’s risks, leaving no doubt about what information veterans are or are not provided,” the groups wrote in the letter.
Nearly 70 percent of veterans receiving VA care are prescribed psychiatric medications, according to the Grunt Style Foundation. The Written Informed Consent Act would require VA providers to follow the same informed-consent protocols for psychiatric medications that are already used when prescribing opioid painkillers.
It would mandate that the VA provide veterans with clear and comprehensive written information before prescribing medications used to treat mood disorders.
The bill covers antidepressants, anti-anxiety medications and other psychiatric drugs. It requires disclosures about potential risks such as suicidal thoughts and behaviors. The legislation specifically names antipsychotics, stimulants, antidepressants, anxiolytics (anti-anxiety drugs) and narcotics as drugs that would require a veteran’s written consent.
Under the proposal, VA health care providers would be required to use a standardized written consent form outlining potential adverse effects. Veterans or their caregivers would also receive a written summary detailing risks, benefits and alternative treatment options. Currently these prescriptions may be accompanied only by verbal disclosures or limited written information.
Republican Representative Gus Bilirakis of Florida is helping lead the legislation in the House. “Our veterans deserve nothing less than complete transparency when it comes to their health and the medications they’re prescribed,” Bilirakis said at a news conference organized by veterans groups outside the Capitol in April. The House version of the bill has 19 co-sponsors.
Democratic Representative Don Davis of North Carolina, an Air Force veteran, is a co-sponsor of the House bill. Republican Representative Tom Barrett of Michigan, an Army veteran, is a co-sponsor of the House bill. The bill now awaits action in both the House and Senate Veterans’ Affairs Committees.
Newsweek reported that with the renewed push from the coalition of veterans’ groups, the legislation could be closer to passage after previous attempts stalled. Charles Garbarino, a retired Army colonel, told Stars and Stripes that if the veteran says ‘I don’t want it,’ their refusal would need to go into their chart.
He added that leaving a serious mental health problem untreated can lead to suicide.
Key Facts
Story Timeline
3 events- 2026-04
Rep. Gus Bilirakis makes statement at news conference organized by veterans groups outside the Capitol
1 sourceNewsweek - 2026-04
Approximately 35 veterans organizations send letter to House and Senate Veterans’ Affairs Committee leaders urging prioritization of Written Informed Consent Act
1 sourceNewsweek - 2026-05-07
Bill with 19 House co-sponsors awaits action in House and Senate Veterans’ Affairs Committees
1 sourceNewsweek
Potential Impact
- 01
Veterans and caregivers would receive explicit written summaries of risks including suicidal thoughts, benefits and alternative treatments before starting medications
- 02
VA providers would shift from verbal or limited written disclosures to mandatory standardized written consent forms for psychiatric drugs
- 03
Potential for increased documentation of patient refusals of psychiatric medications in medical charts
Transparency Panel
Related Stories
Substrate placeholder — needs reviewUS Withdrawal From WHO Could Affect Hantavirus Response
Health officials said the US departure from the World Health Organization may limit immediate access to surveillance data and contact tracing for hantavirus cases linked to a cruise ship. The US formally left the organization in January after 78 years as a member. President Trump…
Substrate placeholder — needs reviewOil Prices Jump After Naval Clashes Between US and Iranian Forces in Strait of Hormuz
Brent crude jumped as much as 7.5 percent to $103.70 per barrel after naval clashes between United States and Iranian forces tested a fragile ceasefire. President Donald Trump said three US destroyers transited the strait under fire without damage while Iranian officials reported…
Al JazeeraPalestinian Detainees Allege Sexual Violence and Abuse in Israeli Prisons
Former Palestinian detainees have described rape, sexual assault, stripping, and other forms of abuse during detention in Israeli facilities. Rights groups documented systematic patterns including seven forms of sexual violence. Israel has not responded to the allegations.